Skip to main content

MoneyWorks4Me

Jagsonpal Pharmaceuticals informs about press release

16 Aug 2021 Evaluate

In terms of regulation 30 of the SEBI (LODR) Regulations, 2015, Jagsonpal Pharmaceuticals has informed that it enclosed a copy of the Press Release on the Unaudited Financial results of the Company for the quarter ended 30th June, 2021.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..